FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 302:542-546 March 6, 1980 Number 10 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Although considerable progress has been made during the past two decades in the use of androgens to prevent attacks of hereditary angioedema, replacement of the deficient C1-inhibitor protein would provide a useful menas of treatment once an attack has begun. We studied the clinical use of C1 inhibitor that was partly purified on a large scale from pooled plasma. The in vivo efficacy and safety of this protein concentrate were evaluated during 11 intravenous infusions in eight patients with hereditary angioedema. Three patients received the C1-inhibitor preparation during an asymptomatic period. Increases in serum C4 activity provided evidence of the biologic activity of the infused inhibitor. Intravenous administration of the concentrate during acute abdominal or laryngeal attacks of hereditary angioedema in five patients resulted in abatement of symptoms in addition to increased serum C4 activity. No untoward effects of the intravenous administration of the C1 inhibitor were observed in these eight patients. Thus, this C1-inhibitor preparation seems to offer the potential for safe, effective replacement therapy and may provide a means of controlling an attack of hereditary angioedema that is in progress.

This article has been cited by other articles:

• Farkas, H., Varga, L., Szeplaki, G., Visy, B., Harmat, G., Bowen, T. (2007). Management of Hereditary Angioedema in Pediatric Patients. Pediatrics 120: e713-e722 [Abstract] [Full Text]  
• Beinrohr, L., Harmat, V., Dobo, J., Lorincz, Z., Gal, P., Zavodszky, P. (2007). C1 Inhibitor Serpin Domain Structure Reveals the Likely Mechanism of Heparin Potentiation and Conformational Disease. J. Biol. Chem. 282: 21100-21109 [Abstract] [Full Text]  
• BORK, K., BARNSTEDT, S.-E. (2003). Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. Journal of the American Dental Association 134: 1088-1094 [Abstract] [Full Text]  
• Bork, K., Hardt, J., Schicketanz, K.-H., Ressel, N. (2003). Clinical Studies of Sudden Upper Airway Obstruction in Patients With Hereditary Angioedema Due to C1 Esterase Inhibitor Deficiency. Arch Intern Med 163: 1229-1235 [Abstract] [Full Text]  
• Fay, A, Abinun, M (2002). Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency). J. Clin. Pathol. 55: 266-270 [Abstract] [Full Text]  
• Bork, K., Barnstedt, S.-E. (2001). Treatment of 193 Episodes of Laryngeal Edema With C1 Inhibitor Concentrate in Patients With Hereditary Angioedema. Arch Intern Med 161: 714-718 [Abstract] [Full Text]  
• Caliezi, C., Wuillemin, W. A., Zeerleder, S., Redondo, M., Eisele, B., Hack, C. E. (2000). C1-Esterase Inhibitor: An Anti-Inflammatory Agent and Its Potential Use in the Treatment of Diseases Other Than Hereditary Angioedema. Pharmacol. Rev. 52: 91-112 [Abstract] [Full Text]  
• Shah, U. K., Jacobs, I. N. (1999). Pediatric Angioedema: Ten Years' Experience. Arch Otolaryngol Head Neck Surg 125: 791-795 [Abstract] [Full Text]  
• Waytes, A. T., Rosen, F. S., Frank, M. M. (1996). Treatment of Hereditary Angioedema with a Vapor-Heated C1 Inhibitor Concentrate. NEJM 334: 1630-1634 [Abstract] [Full Text]